Seneca

Seneca

Seneca Therapeutics, Inc. is pleased to announce the appointment of Cuong Do, MBA, to its Board of Directors. With this new addition, Seneca Therapeutics strengthens its leadership team and further enhances its ability to drive innovation and growth in the field of biotechnology.

Cuong Do brings a wealth of experience and expertise to Seneca Therapeutics. As a seasoned executive with a strong background in business strategy and development, he will play a pivotal role in guiding the company's strategic direction and decision-making processes. His extensive knowledge of the biotechnology industry will be instrumental in driving Seneca Therapeutics' mission to develop and deliver breakthrough therapies to patients in need.

Seneca Therapeutics is committed to advancing the field of biotechnology and improving the lives of patients worldwide. With the appointment of Cuong Do to its Board of Directors, the company is poised to accelerate its growth and make significant contributions to the development of innovative therapies. Seneca Therapeutics remains dedicated to its mission of transforming healthcare through groundbreaking research and development.